Neumora halts trial of depression drug, rethinks 2 others to apply lessons from phase 3 failure
Neumora halted one trial of its depression drug navacaprant and paused another pair of late-stage studies as it tries to learn from a recent phase 3 failure.
Neumora halted one trial of its depression drug navacaprant and paused another pair of late-stage studies as it tries to learn from a recent phase 3 failure.
